AccuStem Sciences, Inc.
ACUT
$0.55
$0.1330.95%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 110.93% | -48.70% | -33.98% | -38.44% | -81.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.26% | -45.16% | -25.38% | -36.81% | -74.86% |
| Operating Income | -51.26% | 45.16% | 25.38% | 36.81% | 74.86% |
| Income Before Tax | -51.26% | 45.16% | 25.38% | 36.81% | 74.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -51.26% | 45.16% | 25.38% | 36.81% | 74.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.26% | 45.16% | 25.38% | 36.81% | 74.86% |
| EBIT | -51.26% | 45.16% | 25.38% | 36.81% | 74.86% |
| EBITDA | -51.45% | 45.23% | 25.42% | 36.85% | 74.93% |
| EPS Basic | -46.54% | 45.16% | 25.53% | 36.78% | 74.83% |
| Normalized Basic EPS | -46.32% | 45.15% | 25.37% | 36.82% | 74.77% |
| EPS Diluted | -46.54% | 45.16% | 25.53% | 36.78% | 74.83% |
| Normalized Diluted EPS | -46.32% | 45.15% | 25.37% | 36.82% | 74.77% |
| Average Basic Shares Outstanding | 3.13% | 0.00% | 0.00% | 0.00% | -0.04% |
| Average Diluted Shares Outstanding | 3.13% | 0.00% | 0.00% | 0.00% | -0.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |